Ballif B C, Theisen A, McDonald-McGinn D M, Zackai E H, Hersh J H, Bejjani B A, Shaffer L G
Signature Genomic Laboratories, LLC, Spokane, WA 99207, USA.
Clin Genet. 2008 Nov;74(5):469-75. doi: 10.1111/j.1399-0004.2008.01094.x. Epub 2008 Sep 20.
We report the identification of microdeletions of 16q11.2q12.2 by microarray-based comparative genomic hybridization (aCGH) in two individuals. The clinical features of these two individuals include hypotonia, gastroesophageal reflux, ear anomalies, and toe deformities. Other features include developmental delay, mental retardation, hypothyroidism, and seizures. The identification of common clinical features in these two individuals and those of one other report suggests microdeletion of 16q12.1q12.2 is a rare, emerging syndrome. These results illustrate that aCGH is particularly suited to identify rare chromosome abnormalities in patients with apparently non-syndromic idiopathic mental retardation and birth defects.
我们报告了通过基于微阵列的比较基因组杂交(aCGH)在两名个体中鉴定出16q11.2q12.2的微缺失。这两名个体的临床特征包括肌张力减退、胃食管反流、耳部异常和脚趾畸形。其他特征包括发育迟缓、智力障碍、甲状腺功能减退和癫痫发作。这两名个体以及另一篇报告中的个体具有共同临床特征,提示16q12.1q12.2微缺失是一种罕见的、新出现的综合征。这些结果表明,aCGH特别适合于识别患有明显非综合征性特发性智力障碍和出生缺陷患者中的罕见染色体异常。